Lv2
122 积分 2023-11-25 加入
Real-World Effectiveness of Tildrakizumab in Japanese Patients With Psoriasis: Analyses Stratified by Prior Systemic Therapy, Maintenance of Early Responses, and Achievement of Delayed Responses
4天前
已关闭
62633 Efficacy and safety of tildrakizumab for the treatment of obese patients with moderate-to-severe plaque psoriasis affecting the scalp: Post hoc analysis of a Phase 3b trial
2个月前
已关闭
63996 Efficacy and safety of tildrakizumab for the treatment of obese patients with moderate-to-severe plaque psoriasis: Post hoc analysis of reSURFACE 1 and reSURFACE 2
2个月前
已关闭
A Multicenter, Randomized, Double-blinded, Placebo-Controlled Phase III Trial to Evaluate Efficacy and Safety of Picankibart in Moderate-to-Severe Plaque Psoriasis
2个月前
已完结
Distinctive DNA sequence features define epigenetic longevity of inflammatory memory
3个月前
已完结
Systemic Pharmacological Treatments for Chronic Plaque Psoriasis
3个月前
已关闭
Biologic and small-molecule therapies for chronic plaque psoriasis in people living with HIV: current evidence and clinical practical considerations
3个月前
已完结
CLINICAL OBSERVATION AND STUDY OF POLIDOCANOL SCLEROTHERAPY FOR KELOIDS UHFUS
4个月前
已关闭
Low-grade systemic inflammation is associated with risk of psoriasis in a general population study of more than 100 000 individuals
4个月前
已完结
Tildrakizumab in Managing Psoriasis with Involvement of Difficult-to-Treat Areas: A Multicenter Real-Life Retrospective Study
5个月前
已完结
皖公网安备34019202002308
